Video

Impact of Long-Acting HIV Prevention Drugs

A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
1 expert in this video
1 expert in this video
1 KOL is featured in this series.
1 expert in this video
Related Content
Aids HIV Virus
June 18th 2025

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Luke Halpern, Assistant Editor
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
July 25th 2024

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

Red ribbon for HIV/AIDS awareness -- Image credit: fizkes | stock.adobe.com
May 23rd 2025

A Student Pharmacist’s Guide to HIV Medications

Zahara Anglin, PharmD Candidate
Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities
February 7th 2024

Public Health Matters: The Pharmacist's Role in the HIV Space, Removing Barriers, Racial Disparities

Man receiving HIV-prevention injection -- Image credit: auremar | stock.adobe.com
March 20th 2025

Expanded Use of Long-Acting Injectables for HIV and HIV Prevention

Allison M. Field, PharmD, BCIDP, AAHIVP Melissa George, PharmD, BCIDP
HIV virus cells. Scientifically accurate human immunodeficiency virus (HIV) close-up view. Acquired immunodeficiency syndrome AIDS 3D medical illustration.
March 19th 2025

New Data on HIV-1 Treatments, Including Biktarvy and Novel Lenacapavir Combination Regimen, Presented at CROI 2025

Luke Halpern, Assistant Editor